Youssef Bennani is a managing partner with over 25 years of pharmaceutical leadership. He led Domain Therapeutics, founded FinD Therapeutics, and held roles at Vertex Pharmaceuticals, Ligand Pharmaceuticals, Abbott Laboratories, and Athersys.
At firms with a similar stage, sector and check size.
One email when Youssef's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckYoussef Bennani is a managing partner with over 25 years of pharmaceutical leadership. He led Domain Therapeutics, founded FinD Therapeutics, and held roles at Vertex Pharmaceuticals, Ligand Pharmaceuticals, Abbott Laboratories, and Athersys.
CTI Life Sciences Fund has not reported a check size. It invests at pre-seed, seed, series a.
A warm intro from a founder CTI Life Sciences Fund backed works best.
Abbott Laboratories; Ligand Pharmaceuticals; Vice President Drug Innovation at Vertex; Site Head and Vice President of R&D at Vertex Pharmaceuticals Canada Inc.; founding CEO at Find Therapeutics; Chairman of the Board at Domain Therapeutics; independent Board Director at Bellus Health.
Last updated 2026-10-15. Is this you? Ask for a correction.